Publicacións en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (10)

2025

  1. Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry

    International Journal of Cardiology, Vol. 419

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  2. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

  2. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  3. The Art of Prescribing β-Blockers After Myocardial Infarction

    Circulation: Cardiovascular Interventions, Vol. 14, Núm. 4, pp. E010720

2019

  1. Role of Beta-blockers in Cardiovascular Disease in 2019

    Revista Espanola de Cardiologia, Vol. 72, Núm. 10, pp. 844-852

  2. The Two-way Relationship Between Cancer and Atherosclerosis

    Revista Espanola de Cardiologia, Vol. 72, Núm. 6, pp. 487-494

2018

  1. Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 2, pp. 280-291

2017

  1. The Swing of β-Blockers: Time for a System Reboot

    Journal of the American College of Cardiology